This website uses cookies so that we can provide the best service possible. For more information, please visit our privacy policy.

sign in


Apr 28, 2020

activity- and affinity-based probes as research tools — design, development and applic.

guest speaker:
Prof. Dr. Martin D. Witte, University of Groningen, The Netherlands
16:00 CEST (Berlin)

The discovery that proteins and/or protein families of interest can be labelled selectively with chemical reagents resulted in an active research field that aims to profile the amount and activity of (a subset of) proteins in a relevant setting. For this purpose, a diverse set of so-called activity- and affinity-based probes (ABPs) have been developed nowadays. The molecular structure of these probes generally consists of a recognition element, which generates selectivity for the protein of interest, a reactive group or warhead, which facilitates covalent binding of the probe to the protein, and a reporter group, which is used for read-out purposes. The activity-based protein profiling field has matured over the past decades and these research tools are nowadays employed in both fundamental and applied settings.

During this webinar, I will introduce the basics of activity- and affinity-based protein profiling. I will describe the general design approaches for ABPs, as well as their applications. In the second part of the webinar, I will discuss novel combinatorial approaches to prepare probes and I will demonstrate how chemical probes can be combined with nanoLC-MS/MS and docking studies to map the binding sites of small molecules.

web address

Mar 19, 2020

computational toxicology — from models to workflows

guest speaker:
Prof. Dr. Gerhard F. Ecker, University of Vienna & Phenaris GmbH, Vienna, Austria

Feb 19, 2020

new applications of dynamic combinatorial chemistry to medicinal chemistry

Dr. Alwin Hartman, Principal Scientist at BioSolveIT, St. Augustin, Germany

Jan 28, 2020

bridging the dimensions: multi-parameter optimisation of 2D and 3D SAR

guest speaker:
Dr. Matthew Segall, CEO at Optibrium Ltd, Cambridge, United Kingdom

load more


© 2020 BioSolveIT GmbH,   all rights reserved